Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM

S. Genovese, R. Bonfanti, E. Bazzigaluppi, V. Lampasona, E. Benazzi, E. Bosi, G. Chiumello, E. Bonifacio

Research output: Contribution to journalArticle

Abstract

Insulin, glutamate decarboxylase (GAD) and the protein tyrosine phosphatase-like molecule IA-2 are major targets of humoral autoimmunity in insulin-dependent diabetes mellitus (IDDM). These autoantibodies are heterogeneous with respect to age and patient human leukocyte antigen (HLA) phenotype. We have previously demonstrated that GAD and IA-2 antibodies potentially identify different subsets of IDDM patients. The aim of this study was to determine whether GAD and IA-2 autoantibodies were associated with different HLA DR phenotypes. We studied 160 patients with IDDM onset before age 16 years. At disease onset serum was tested for GAD and IA-2 antibodies by immunoprecipitation of in vitro-translated 35S-methionine labelled recombinant proteins. IA-2 antibodies were significantly associated with HLA DR4: 67 (86%) of 78 patients with HLA DR4 vs 31 (38%) of 82 non-DR4 patients had IA-2 antibodies (p(c) <0.0001) and IA-2 antibody levels were higher in patients with HLA DR4 (p(c) <0.0001). In contrast, GAD antibodies were more prevalent (p(c) <0.05) and antibody levels highest (p(c) <0.01) inpatients with HLA DR3 phenotypes. These data provide further evidence that, in IDDM, production and titre of major autoantibody specificities are associated with HLA class II alleles.

Original languageEnglish
Pages (from-to)1223-1226
Number of pages4
JournalDiabetologia
Volume39
Issue number10
Publication statusPublished - 1996

    Fingerprint

Keywords

  • Autoantibodies
  • Glutamic acid decarboxylase
  • HLA
  • IA-2
  • Insulin-dependent diabetes mellitus

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Genovese, S., Bonfanti, R., Bazzigaluppi, E., Lampasona, V., Benazzi, E., Bosi, E., Chiumello, G., & Bonifacio, E. (1996). Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Diabetologia, 39(10), 1223-1226.